Urothelial Neoplasms

79 slides · PPTX & PDF available

Download PDF

Request PowerPoint

PowerPoint animations are preserved in the original file.

Slide index (79)

Loading slide titles…

Loading presentation…

Swipe on touchscreens · Use ← / → to change slides, Home / End to jump.

Lecture topics

Urothelial tumors dominate bladder neoplasia
Cigarette smoking: Dominant exposure
Two routes are models, not absolutes
PUNLMP versus papilloma
CIS frequently involves a broad field
AJCC 8th: Non–muscle-invasive pT categories
Clinical categories: NMIBC versus MIBC
Primary references and scope

Slide index & full transcript (79 slides)

Text from the original slides, in presentation order. Diagrams and images remain in the viewer above.

Slide 1 · Urothelial Neoplasms

From benign papilloma to deeply invasive carcinoma

Papillary and flat pathways; morphology, grade, invasion, and clinical behavior

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Identify papillary and flat urothelial precursor lesions

Compare papilloma, PUNLMP, and low-/high-grade papillary carcinoma

Relate invasion depth to pT category and prognosis

Integrate clinical presentation, recurrence, and surveillance

Slide 3 · Urothelial tumors dominate bladder neoplasia

Urothelial lesions account for approximately 90% of bladder tumors

The biologic range extends from harmless papilloma to lethal invasive carcinoma

Squamous, glandular, and other bladder tumors are separate categories

~90%

Of bladder tumors are urothelial

Slide 4 · A disease of the entire urothelial tract

Tumors are most common in the bladder

Similar urothelial lesions can occur from renal pelvis to distal urethra

Multifocal disease may be present at initial examination

This distribution helps explain the clinical importance of field-wide evaluation

Renal pelvis

Ureter

Urinary bladder

Urethra

Schematic · not a histologic specimen

Slide 5 · Normal bladder wall: Layers that matter

Urothelium overlies the basement membrane

Lamina propria is the subepithelial connective tissue

Muscularis propria is the detrusor muscle

Depth of invasion determines key stage boundaries

Urothelium

Lamina propria

Muscularis propria

Perivesical tissue

Basement membrane intact

Schematic · not a histologic specimen

Slide 6 · Four broad growth patterns

Exophytic noninvasive papillary neoplasm

Flat noninvasive carcinoma in situ (CIS)

Invasive papillary carcinoma

Invasive carcinoma associated with flat CIS

Noninvasive growth

Invasive growth

Papillary lesion

Papillary with invasion

Flat CIS

Flat CIS with invasion

Slide 7 · Two principal precursor routes

Papillary-enriched route

Growth signaling: FGFR3 / RAS

Noninvasive papillary neoplasm

Usually recurrence; Sometimes invasion

Flat CIS-enriched route

Checkpoint changes: TP53 / RB

Flat high-grade CIS

Potential invasion

Slide 8 · Noninvasive is not synonymous with low grade

Papillary lesions span multiple histologic grades

Flat CIS is high-grade by definition

Neither Ta papillary carcinoma nor Tis CIS crosses the basement membrane

Grade and stage answer different questions

Grade

Stage

Cytologic/architectural atypia

Anatomic extent

Biologic aggressiveness

Basement membrane and depth

Slide 9 · WHO 2022: Noninvasive flat lesions

Flat lesion

Key principle

Urothelial dysplasia

Flat atypical urothelial lesion

Urothelial CIS

Flat, high-grade noninvasive carcinoma

Slide 10 · WHO 2022: Exophytic papillary lesions

Papilloma

Papillary urothelial neoplasm of low malignant potential (PUNLMP)

Low-grade papillary urothelial carcinoma

High-grade papillary urothelial carcinoma

Papilloma

PUNLMP

Low-grade carcinoma

High-grade carcinoma

Schematic · not a histologic specimen

Slide 11 · Grade must be separated from invasion

Low-grade papillary lesions often remain non–muscle-invasive

High-grade papillary lesions have a substantially greater potential to progress

CIS is high-grade but initially flat and noninvasive

Muscularis propria invasion defines a major clinical transition

Microscopic grade

Anatomic stage

Low vs high cytologic atypia

Ta / Tis / T1

Order and cellular polarity

T2 and beyond

Slide 12 · Epidemiology: Demographic pattern

Male-to-female incidence ratio is approximately 3:1

About 80% of patients are 50–80 years old

Higher incidence in higher-income countries and urban populations

Most bladder cancers are sporadic rather than familial

3 : 1

Male-to-female incidence ratio

Slide 13 · Cigarette smoking: Dominant exposure

Most important established risk factor

Associated risk rises about three- to seven-fold

Risk varies with duration and tobacco exposure type

Cigarette-related carcinogenesis links environment and urothelial mutations

3–7×

Smoking-associated relative risk range

Slide 14 · Smoking-attributable burden in males

Textbook estimates 50%–80% of bladder cancers among males are associated with cigarette use

This is an epidemiologic association, not an individual diagnostic test

Cigars, pipes, and smokeless tobacco show smaller associations than cigarettes

50–80%

Male bladder cancers associated with cigarettes

Slide 15 · Aryl amines and occupational exposure

Industrial aryl amines are established urothelial carcinogens

2-Naphthylamine is the classic example

Carcinogenic exposure can precede cancer by decades

Exposure history should include remote occupations

Industrial exposure

Aryl amine contact

Long latency

Urothelial cancer

Schematic · not a histologic specimen

Slide 16 · Exposure-to-cancer latency

The cited interval after initial industrial exposure is 15–40 years

Remote exposures may be clinically relevant even after retirement

Latency does not identify the grade or stage of an eventual tumor

15–40 y

Reported interval after first aryl-amine exposure

Slide 17 · Other etiologic influences

Exposure

Relevant context

Cyclophosphamide

Hemorrhagic cystitis and later neoplasia

Pelvic irradiation

Cancer arising several years later

Analgesics

Long-term exposure implicated

Slide 18 · Schistosomal bladder carcinogenesis

Schistosoma haematobium eggs induce chronic bladder-wall inflammation

Chronic injury can promote squamous metaplasia and dysplasia

In endemic regions, associated cancers are more commonly squamous

This is a differential-context risk factor, not the dominant papillary urothelial route

Ova in bladder wall

Chronic inflammation

Squamous metaplasia / dysplasia

Neoplasia

Schematic · not a histologic specimen

Slide 19 · Epidemiology is not tumor classification

Smoking and other exposures increase the probability of urothelial malignancy

Morphology still establishes tumor type and grade

Invasion determines stage independently of exposure history

Avoid inferring subtype from a single risk factor

Slide 20 · Pathogenesis: Two broad molecular routes

Papillary-enriched route

Growth signaling: FGFR3 / RAS

Noninvasive papillary neoplasm

Usually recurrence; Sometimes invasion

Flat CIS-enriched route

Checkpoint changes: TP53 / RB

Flat high-grade CIS

Potential invasion

Slide 21 · Papillary pathway: FGFR3 signaling

Amplification or activation of FGFR3 is characteristic of a papillary pathway

Enhanced receptor-driven growth contributes to papillary proliferation

Many such tumors recur without becoming muscle-invasive

FGFR3 is a biologic driver; Molecular status is not itself a pT category

Growth-factor pathway change

FGFR3 gain of function

Papillary tumor growth

Recurrent noninvasive disease

Schematic · not a histologic specimen

Slide 22 · Papillary pathway: RAS and PI3K

Activating RAS alterations are described

PI 3-kinase pathway gene alterations can also enhance growth signaling

These mechanisms converge on increased proliferative input

Not every papillary lesion requires all of these events

RAS / PI3K activation

Increased signaling

Urothelial proliferation

Papillary neoplasm

Schematic · not a histologic specimen

Slide 23 · CIS-associated pathway: TP53 and RB

TP53 and RB disruption is prominent in muscle-invasive carcinoma

These alterations may occur early in CIS development

Comparable checkpoint disruption can appear later in some papillary cancers

The route reflects impaired cell-cycle and genomic safeguards

TP53 / RB inactivation

Checkpoint dysfunction

High-grade flat lesion

Potential invasive carcinoma

Schematic · not a histologic specimen

Slide 24 · Two routes are models, not absolutes

Approximately 20% progression to muscle-invasive disease is cited for papillary non–muscle-invasive cancers in the molecular discussion

The routes overlap as carcinomas accumulate alterations

A high-grade papillary component may coexist with CIS

Molecular findings must be interpreted beside morphology and invasion

Papillary-enriched route

CIS-enriched route

FGFR3 / RAS / PI3K

TP53 / RB disruption

Often NMIBC

Often precursor to MIBC

Slide 25 · High somatic mutational burden

Bladder cancers have substantial somatic mutation loads

The textbook compares this burden with lung cancer and melanoma

This pattern is consistent with important environmental carcinogenic effects

Mutation burden alone does not specify stage or morphology

Slide 26 · Broader molecular heterogeneity

Altered cellular function

Illustrative category

Cell-cycle control

TP53 / RB-related checkpoint pathways

Growth signaling

FGFR3 / RAS / PI3K pathways

Other processes

Chromatin regulation; DNA repair

Slide 27 · The diagnostic priority remains morphologic

Molecular classification continues to develop

The supplied source emphasizes tumor morphology, grade, and stage

Do not substitute a mutation for demonstration of invasion

Clinical interpretation integrates molecular and traditional pathology

Slide 28 · Gross appearance: Papillary tumors

Exophytic fronds project into the bladder lumen

Tumors may be red and elevated

Lesions from less than 1 cm to roughly 5 cm

Multifocal, discrete papillary masses can occur

Papillary projections

Schematic · not a histologic specimen

Slide 29 · Papillary versus flat lesions at cystoscopy

Papillary tumors form protruding intraluminal lesions

CIS typically gives erythema, granularity, or mucosal thickening

CIS may not form a discrete mass

Cystoscopic appearance alone cannot establish grade or invasion

Papillary

Flat CIS

Raised mucosal fronds

Red/granular surface

Visible projecting lesion

No obligatory luminal mass

Slide 30 · Papilloma: Architecture of a benign frond

Uncommon lesion, no more than about 1% of bladder tumors

Often solitary and small, attached by a delicate stalk

Finger-like fronds contain central fibrovascular cores

Covering urothelium resembles normal urothelium

Bland fronds + fibrovascular cores

Schematic · not a histologic specimen

Slide 31 · Papilloma: Expected behavior

Typically seen in younger patients than ordinary bladder carcinoma

Recurrence is unusual but can occur

Progression is rare

Morphologic distinction from thicker papillary lesions matters

Slide 32 · Inverted papilloma: Deceptively endophytic

Bland urothelial cords grow down into lamina propria

Cords interanastomose rather than form external fronds

Despite downward growth, this is considered benign

It can mimic infiltrating carcinoma in a limited sample

Bland endophytic, interconnected cords

Schematic · not a histologic specimen

Slide 33 · PUNLMP: Increased urothelial thickness

Thicker papillary epithelium with increased cell density

Retains many features of papilloma

May be grossly indistinguishable from papillary carcinoma

Higher-grade progression is possible but uncommon

Increased urothelial thickness

Schematic · not a histologic specimen

Slide 34 · PUNLMP versus papilloma

The distinction turns on cellular density and epithelial thickness

Both retain relatively bland cytology

PUNLMP is not equivalent to high-grade carcinoma

Histologic assessment is essential when gross features overlap

Papilloma

PUNLMP

Normal-like epithelial thickness

Increased epithelial thickness

Delicate fronds

Greater urothelial cellularity

Slide 35 · Low-grade papillary carcinoma: Retained order

Urothelial cells remain mostly cohesive

Overall polarity and architectural order persist

Nuclear size and shape vary mildly

Hyperchromatic nuclei and mitoses may be scattered

Orderly cells; Mild nuclear atypia

Schematic · not a histologic specimen

Slide 36 · Low-grade carcinoma: Mitotic pattern

Mitotic figures are infrequent

When present, mitoses tend to occur toward the epithelial base

Cytologic atypia is modest rather than absent

The distinction from PUNLMP depends on integrated architecture and cytology

Slide 37 · High-grade papillary carcinoma: Cytologic disorder

Large hyperchromatic and irregular nuclei

Prominent nucleoli and marked cellular atypia

Frequent mitoses, sometimes atypical

Cells may lose cohesiveness and normal polarity

Crowding and marked atypia

Schematic · not a histologic specimen

Slide 38 · High grade: Invasion is a separate question

A very atypical papillary lesion can remain noninvasive (Ta)

The same lesion may invade lamina propria or detrusor

Grade predicts biologic behavior but cannot replace staging

Report the presence and depth of invasion explicitly

Urothelium

Lamina propria

Muscularis propria

Perivesical tissue

Tumor enters lamina propria

Schematic · not a histologic specimen

Slide 39 · Papillary grading: Integrated comparison

Lesion

Architecture / cytology

Papilloma

Delicate; Normal-like lining

PUNLMP

Thickened, crowded; Bland

Low-grade carcinoma

Mostly ordered; Mild atypia

High-grade carcinoma

Disordered; Severe atypia

Slide 40 · Recurrence does not equal progression

Recurrence means a new detected lesion after treatment

Progression implies greater grade and/or anatomic extent

Low-grade tumors can recur repeatedly without becoming muscle-invasive

High-grade papillary tumors have a greater progression risk

Recurrence

Progression

Tumor returns

Worsening biologic extent

May remain same grade / stage

New invasion or grade escalation

Slide 41 · Carcinoma in situ: Flat and malignant

CIS is high-grade urothelial carcinoma confined to epithelial lining

It does not penetrate the basement membrane

The affected surface can be subtle at cystoscopy

CIS differs categorically from invasive carcinoma

Urothelium

Lamina propria

Muscularis propria

Perivesical tissue

CIS

Basement membrane intact

Schematic · not a histologic specimen

Slide 42 · CIS: The cytologic hallmark

Marked nuclear enlargement and pleomorphism

Disorganization of the urothelial lining

High-grade atypia may involve much or part of the epithelium

Apparent flattening does not make the lesion biologically bland

Slide 43 · Pagetoid CIS: Scattered malignant cells

Malignant cells may be scattered among relatively normal urothelial cells

The entire epithelium need not appear uniformly replaced

Careful search is necessary in subtle lesions

Pagetoid distribution still represents high-grade flat carcinoma

Scattered malignant cells within epithelium

Schematic · not a histologic specimen

Slide 44 · CIS can become denuded

CIS cells often lose normal intercellular cohesion

Malignant cells exfoliate into urine

After extensive shedding, only a few abnormal cells may remain attached

A denuded surface can complicate histologic interpretation

Surface denudation after loss of cohesion

Schematic · not a histologic specimen

Slide 45 · CIS frequently involves a broad field

CIS is commonly multifocal

Bladder involvement may be extensive

It can extend into ureters and urethra

An isolated-looking mucosal abnormality may underestimate distribution

Focal CIS

Multifocal bladder sites

Broad urothelial involvement

Possible tract extension

Schematic · not a histologic specimen

Slide 46 · CIS: Risk of untreated progression

50%–75% progression to invasive carcinoma if untreated

The quoted figure concerns untreated CIS, not any flat atypia

Early recognition and appropriate clinical management are consequential

50–75%

Untreated CIS progressing to invasion (textbook)

Slide 47 · Invasive carcinoma: Loss of anatomic containment

The epithelial basement membrane is crossed

Tumor infiltrates lamina propria and can involve detrusor muscle

Invasion must be distinguished from downgrowth of benign lesions

Stage is defined by the deepest involved compartment

Urothelium

Lamina propria

Muscularis propria

Perivesical tissue

Tumor penetrates detrusor

Schematic · not a histologic specimen

Slide 48 · Lamina propria invasion: T1

Neoplastic cells extend into subepithelial connective tissue

Muscularis propria is not invaded at T1

This worsens prognosis compared with purely noninvasive disease

T1 is still within the non–muscle-invasive management category

Urothelium

Lamina propria

Muscularis propria

Perivesical tissue

Tumor enters lamina propria

Schematic · not a histologic specimen

Slide 49 · Muscularis propria invasion: T2

Tumor reaches detrusor muscle

This is the central stage distinction in clinical decision-making

A marked decrease in survival with muscle invasion

Involvement of muscularis mucosae alone is not equivalent to detrusor invasion

Urothelium

Lamina propria

Muscularis propria

Perivesical tissue

Tumor penetrates detrusor

Schematic · not a histologic specimen

Slide 50 · Muscle invasion transforms the clinical problem

Tumor has access to deeper bladder-wall structures

Regional nodal and systemic spread become major concerns

Source examples of distant deposits include liver and lung

Accurate recognition of detrusor invasion is indispensable

Muscularis propria invasion

Higher metastatic potential

Regional lymph nodes

Possible distant disease

Schematic · not a histologic specimen

Slide 51 · Advanced invasive tumor: Gross features

Large nodular or fungating masses can occur

Ulceration and tumor necrosis may be present

Infiltrative extension widens the tumor footprint

An advanced mass may obscure the original precursor lesion

Slide 52 · Variants: Architecture may mislead

Examples

Diagnostic significance

Nested / large nested

Bland-looking architecture can mislead

Micropapillary

Unusual growth pattern

Plasmacytoid / sarcomatoid

Nonconventional morphology

Other listed subtypes

Microcystic, tubular, giant-cell, etc.

Slide 53 · Nested carcinoma: Benign-looking cytology trap

A nested variant may have deceptively bland cellular features

Infiltrative distribution is more informative than cytology alone

Distinguish from benign inverted papilloma

The correct diagnostic context requires full sampling and invasion assessment

N category

Regional lymph-node extent

Single true-pelvic node

Multiple true-pelvic nodes

Common iliac node(s)

Slide 60 · Distant metastatic staging

M category

Meaning

M1a

Distant nonregional nodes only

M1b

Distant deposits outside lymph nodes

Slide 61 · Staging summary: What the pathologist answers

Is the lesion flat or papillary and noninvasive?

Does invasion involve lamina propria?

Is muscularis propria actually present and involved?

Is there extravesical or adjacent-organ involvement?

Ta/Tis

Urothelium

Lamina propria

Muscularis propria

Perivesical tissue

Adjacent structures

Schematic · not a histologic specimen

Slide 62 · Painless hematuria: Classical presentation

Most common presenting symptom of bladder carcinoma

Absence of pain does not imply a benign lesion

Textbook highlights investigation using cystoscopy and/or urine cytology

Diagnosis requires tissue assessment when a suspicious lesion is found

Painless hematuria

Clinical investigation

Cystoscopy / cytology

Tissue diagnosis

Schematic · not a histologic specimen

Slide 63 · Irritative and obstructive manifestations

Frequency, urgency, or dysuria can accompany hematuria

Tumor near a ureteral orifice may cause obstruction

Consequences can include hydronephrosis and pyelonephritis

Symptoms do not establish stage in isolation

Slide 64 · Cystoscopy, sampling, and histopathology

Cystoscopy localizes visible papillary or flat mucosal abnormalities

Transurethral resection provides tissue for grade and invasion assessment

A specimen must be examined for lamina propria and detrusor involvement

Urine-based assays do not replace anatomical tumor staging

Visualize mucosa

Resect / biopsy

Assess grade

Determine invasion

Schematic · not a histologic specimen

Slide 65 · What a useful pathology report resolves

Histologic lesion type and urothelial grade

Presence or absence of lamina propria invasion

Whether muscularis propria is sampled and involved

Additional patterns or variants when identified

Slide 66 · Clinical categories: NMIBC versus MIBC

Non–muscle-invasive cancer encompasses Ta, Tis, and T1 categories

Textbook states about 70%–80% are non–muscle-invasive at presentation

Approximately 20%–30% of bladder cancers are muscle-invasive

This split strongly influences management and surveillance

NMIBC

MIBC

Ta / Tis / T1

T2 and higher

No detrusor invasion

Detrusor or deeper invasion

Slide 67 · Localized low-grade papillary disease

Textbook describes diagnostic transurethral resection as sufficient for selected small localized low-grade tumors

This description must not be mistaken for a universal modern treatment algorithm

Appropriate treatment varies with grade, extent, recurrence, and stage

Slide 68 · Intravesical BCG in higher-risk NMIBC

BCG for CIS and selected higher-risk papillary disease

Examples include large, high-grade, multifocal, recurrent, or T1 lesions

BCG produces a local inflammatory antitumor response

Treatment specifics depend on clinical risk stratification

High-risk NMIBC / CIS

Intravesical BCG

Local immune inflammation

Antitumor effect

Schematic · not a histologic specimen

Slide 69 · Why non–muscle-invasive tumors recur

Clonally related recurrence

Tumor-cell shedding

Implantation elsewhere

Clonally related lesion

Independent second primary

New independent clone

Second primary tumor

Another bladder site

Slide 70 · Surveillance is an essential part of care

Even low-grade lesions may recur

High-grade and CIS lesions have meaningful progression risk

Lifelong follow-up is emphasized in the source

No urine-based recurrence assay has replaced cystoscopy account

Slide 71 · Management changes after detrusor invasion

Textbook describes radical cystectomy or selected radiation-based approaches

Systemic chemotherapy is considered in the perioperative setting

Muscle invasion creates substantial risk of nodal and systemic spread

This is a source summary, not a current guideline prescription

Slide 72 · Advanced or metastatic disease

Regional nodes and distant organs may become involved

Textbook discusses checkpoint blockade in a subset of metastatic tumors

Antibody–drug conjugates and molecularly targeted approaches are noted

Specific treatment recommendations require current oncology guidelines

Slide 73 · Stage outweighs gross appearance for prognosis

Papillary shape alone does not establish stage

Depth of infiltration is the major determinant of prognosis

Muscle invasion signals a substantial survival decrement

Source survival figures are textbook cohort summaries, not individual predictions

Urothelium

Lamina propria

Muscularis propria

Perivesical tissue

Tumor penetrates detrusor

Schematic · not a histologic specimen

Slide 74 · Case 1: A recurrent papillary lesion

A small papillary lesion shows ordered cells, mild atypia, and no invasion

Several years later, a morphologically similar lesion reappears elsewhere

Question: Does this establish progression?

Interpret recurrence separately from stage or grade progression

DISCUSSION

What observation determines the pathologic category?

Answer and rationale are recorded in the presenter notes.

Slide 75 · Case 2: A flat erythematous mucosa

Biopsy shows enlarged pleomorphic urothelial cells

Tumor remains above an intact basement membrane

Question: Is this benign because no invasion is visible?

The morphologic diagnosis is high-grade carcinoma in situ

DISCUSSION

What observation determines the pathologic category?

Answer and rationale are recorded in the presenter notes.

Slide 76 · Case 3: Papillary tumor with detrusor nests

Histology identifies urothelial carcinoma within muscularis propria

Even if the surface is papillary, depth determines a pT2 category

Question: Which finding most changes clinical management?

The presence of detrusor invasion is decisive

DISCUSSION

What observation determines the pathologic category?

Answer and rationale are recorded in the presenter notes.

Slide 77 · Integrated clinicopathologic model

Risk factors and molecular pathways create susceptibility

Architecture and cytology classify the urothelial lesion

Tissue layers determine anatomic pT stage

Treatment and prognosis are guided chiefly by stage and grade

Etiologic exposures

Molecular lesions

Morphology + grade

Depth + stage

Clinical decisions

Schematic · not a histologic specimen

Slide 78 · Five distinctions worth retaining

Papillary versus flat describes growth pattern

Low grade versus high grade describes malignancy-related cytology

Noninvasive versus invasive describes basement membrane penetration

T1 versus T2 separates lamina propria from detrusor invasion

Recurrence versus progression describes distinct clinical events

Slide 79 · Primary references and scope

Robbins, Cotran & Kumar: Pathologic Basis of Disease, 11th ed. (2026), Ch. 21, pp. 870–874

WHO Classification of Noninvasive Urothelial Tumors (2022), as reproduced in Robbins Table 21.3

AJCC urinary bladder pTNM staging, 8th edition, as reproduced in Robbins Table 21.4

Clinical treatment details are a textbook summary; confirm contemporary management separately